The Advisory and Oversight team at Mitotherapeutix consists of board members and specialized advisors who provide strategic guidance, assess business risks, and ensure regulatory compliance. Their collective expertise helps in making informed decisions regarding the development and commercialization of siRNA-based drugs.
View all